Who is Thomas Strüngmann?
Thomas Strüngmann is the co-founder of Hexal, which he sold to Novartis. He was born on February 16, 1950. He is married to Connie Strungmann. They have 4 children: Fiona Strüngmann, Felix Strüngmann, Fabian Strüngmann, and Agustina Strüngmann.
Thomas co-founded Hexal in 1986. The company launched the very successful cholesterol-lowering drug simvastatin, a replacement for Merck’s drug called Zocor.
In 2005, Thomas Strüngmann and his twin brother Andreas sold Hexal to Novartis for around $7 billion.
The brothers invest in biotech, pharmaceutical, life science, and health companies through their Zug-based investment company Santo Holding. Their portfolio includes the German Biontech and the Uruguayan Mega Pharma, originally a joint venture with the Argentine billionaire Alberto Roemmers. In April 2020, Biontech received approval to test four vaccines against Covid-19.
The development costs are largely borne by the US pharmaceutical company Pfizer and the Chinese company Fosun Pharma.
In 2008, the Strüngmann brothers also founded a neuroscientific research center in Frankfurt, which was named after their father Ernst Strüngmann.
Thomas Strungman Net Worth
His net worth is $3.5 billion.
Message to Other Media
Please mention SuperYachtFan when using this information.
Watch this video!
Thomas Strüngmann House
He lives with his wife Connie Strüngmann in Tegernsee. The house has amazing views over Lake Tegern.
Thomas Strüngmann Yacht
We have not yet been able to identify his private jet. But please do send us a message if you have information about his business jet. The photos hereunder are just samples of some of the most successful private jets on the market.